Ledyard National Bank Laboratory Corp Of America Holdings Transaction History

Ledyard National Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 18, 2022	SELL	$204.81 - $262.19 $11,059 - $14,158	-54 Reduced 0.28%	19,047 $3.9 Million
Q2 2022 Jul 19, 2022	SELL	$213.86 - $277.87 $110,565 - $143,658	-517 Reduced 2.64%	19,101 $4.48 Million
Q1 2022 Apr 25, 2022	BUY	$259.82 - $298.18 $5.1 Million - $5.85 Million	19,618 New	19,618 $5.17 Million
Q1 2019 Apr 12, 2019	SELL	$123.7 - $156.3 $8,287 - $10,472	-67 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$120.82 - $174.09 $7,249 - $10,445	60 Added 857.14%	67 $8,000
Q3 2018 Oct 24, 2018	BUY	$167.67 - $188.27 $1,173 - $1,317	7 New	7 $1,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

Stay updated on Ledyard National Bank with notifications on news.